An Open-Label, Single-Dose, Randomized, Cross-Over Study To Estimate The Bioavailability And Food Effect Of 4 Mg Fesoterodine Extended Release Beads-In-Capsule Formulations Compared To Commercial Tablet Formulation In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2012
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- 14 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Feb 2011 New trial record